Biofrontera logo
Biofrontera
BFRI | NASDAQ
Chart Builder DCF Calculator
$0.57
-$0.13 (-18.58%)
At close: Nov 16, 2026, 4:00 PM ET
$0.58
+$0.02 (+2.63%)
After-hours: Nov 16, 2026, 5:23 PM ET

Biofrontera Company Profile

Company profile explained

Company Profile

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Key Executives

Name Position
Hermann Luebbert Chief Executive Officer, President & Chairman
Eugene Frederick Leffler Chief Financial Officer
Daniel Hakansson Senior Corporate Counsel
Erica F. Gates VP of Finance & Principal Accounting Officer
George Jones Chief Commercial Officer
Jon Lyons Vice President of Scientific & Medical Affairs
Samantha Widdicombe Senior Vice President of Sales & Strategic Accounts

Latest SEC Filings

Date Type Title
Oct 30, 2026 25-NSE Filing
Sep 14, 2026 8-K Current Report
Aug 13, 2026 10-Q Quarterly Report
Aug 13, 2026 8-K Current Report
Aug 12, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Jul 29, 2026 4 Filing
Jul 29, 2026 4 Filing
Jul 22, 2026 S-8 Filing
Jul 22, 2026 10-K/A [Amend] Annual Report
Jun 17, 2026 8-K Current Report
View All SEC Filings ➞
Biofrontera
Biofrontera logo
Country United States
IPO Date Oct 29, 2021
Industry Medical - Pharmaceuticals
Sector Healthcare
Employees 89
CEO Hermann Lübbert

Contact Details

660 Main Street Woburn, Massachusetts 01801 United States

Stock Details

Ticker Symbol BFRI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001858685
CUSIP Number 09077D209
ISIN Number US09077D2099
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.